Pharmafile Logo
Pharmafocus logo
Advanced Search

Sackler-owned Mundipharma acquires biosimilar firm Cinfa Biotech

October 10, 2018
Research and Development Mundipharma, biosimilar, cinfa biotech, sackler

In a bid to strengthen their biosimilar portfolio, the Cambridge based pain management company Mundipharma has acquired biosimilar development firm …

News
novartis_outside_1

Novartis’ sickle cell drug reduces vaso-occlusive crises by 35% at Phase 2

October 10, 2018
Research and Development Novartis, crizanlizumab, pharma, sickle cell disease

Novartis has presented new Phase 2 data for its humanised anti-P-selectin monoclonal antibody crizanlizumab in the treatment of sickle cell …

News
14012226029_debf038610_z

WHO voices concern over British immigration policies after researchers refused entry

October 10, 2018
Research and Development WHO, academia, immigration, research, universities

The World Health Organization (WHO) has expressed concern over the UK’s immigration polices, after a number of academics were refused …

News
martin_van_trieste

Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO

October 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals

Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …

Appointment

Menlo Therapeutics’ cough drug fails to meet primary endpoint in phase II trial

October 9, 2018
Manufacturing and Production Phase II, cough, menlo therapeutics, serlopitant

The Redwood City, California-based late stage biopharmaceutical company Menlo Therapeutics have announced that experimental drug serlopitant has failed to meet …

News
janssen_latest_logo_on_sign_closer

Janssen’s Stelara shows promise across two dosages in ulcerative colitis

October 9, 2018
Manufacturing and Production, Research and Development Janssen, Stelara, pharma, ulcerative colitis

Janssen’s biologic therapy Stelara (ustekinumab) has shown new efficacy in the treatment of moderate to severe ulcerative colitis in two …

News
nice_new_london_office_internal_2_8

NICE guidelines on antidepressant withdrawal symptoms are misleading, study shows

October 9, 2018
Manufacturing and Production NICE, UK, addiction, antidepressants, research, study

Current NICE guidance concerning the severity of the effects of antidepressant withdrawal is misleading doctors according to research published in …

News
celgene_1_02

Celgene’s Otezla impresses at Phase 3 in scalp psoriasis

October 9, 2018
Manufacturing and Production, Research and Development Celgene, pharma, psoriasis

Celgene has unveiled new Phase 3 data for Otezla (apremilast), its inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine …

News
shutterstock_138095450_13

New hospital-led organisation aims to tackle drug pricing problem by manufacturing generic drugs

October 9, 2018
Manufacturing and Production PhRMA, aha, generics, hospitals, non profit, non-profit, pharma

Seven organisations representing around 500 US hospitals have become the governing members of a newly established initiative aimed at reducing …

News
capture

The economics of mental health

October 8, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, health economics and outcomes research, mental health, pharma

Louis Goss examines mental health from a health economics and outcomes research (HEOR) perspective and asks what might be done …

Feature

NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia

October 8, 2018
Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma

NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …

News
nhs_andrew_tatlow

NIHR whitepaper claims UK needs High Throughput Centres after Brexit

October 8, 2018
Sales and Marketing NHS, NIHR, UK, clinical trials, phase III

The National Institute for Health Research (NIHR) has released a new whitepaper outlining the substantial benefits NHS High Throughput Centres …

News
alzheimers_sq

Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership

October 8, 2018
Research and Development, Sales and Marketing Alzheimer's, pharma, tencent

Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …

News

US FDA approves HPV vaccine for men and women aged 27-45

October 8, 2018
Sales and Marketing CDC, Cancer, FDA, HPV, approval, infectious diseases, vaccines

The US Food and Drug Administration have approved the use of HPV vaccine Gardasil 9 for both men and woman …

News
msd

MSD signs $117m deal with Samsung Bioepis over Janssen biosimilar

October 8, 2018
Sales and Marketing Biogen, Janssen, MSD, Samsung, Samsung Bioepis

American multinational MSD have won a $117 million contract allowing them to supply Samsung Bioepis’ Renflexis to the US Department …

News
gsk_boronia_australia

GSK to cut almost 200 jobs at UK site

October 5, 2018
Manufacturing and Production, Medical Communications GSK, UK, Ulverston, job cuts, pharma

GlaxoSmithKline has announced that it is to slash half of its workforce at its site in Ulverston, UK, as part …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 5, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10

As September came to a close and October began the UK was hit hard in the headlines after American firm …

News
roche_dark_0

FDA expands indication of Roche’s Hemlibra in haemophilia

October 5, 2018
Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma

The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …

News
gilead_hq_at_stockley_park_london_2

NHS England appoves Gilead’s CAR T therapy Yescarta

October 5, 2018
Medical Communications Gilead, NHS, NICE, UK, Yescarta

Gilead’s CAR T therapy Yescarta is set to be made available on the NHS in England for adults with aggressive …

News
european_commission_web_5

MHRA to consult on potential for no-deal Brexit

October 5, 2018
Medical Communications EU, MHRA, brexit, uk politics

The Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026